JP4829496B2 - 代謝表現型 - Google Patents

代謝表現型 Download PDF

Info

Publication number
JP4829496B2
JP4829496B2 JP2004514009A JP2004514009A JP4829496B2 JP 4829496 B2 JP4829496 B2 JP 4829496B2 JP 2004514009 A JP2004514009 A JP 2004514009A JP 2004514009 A JP2004514009 A JP 2004514009A JP 4829496 B2 JP4829496 B2 JP 4829496B2
Authority
JP
Japan
Prior art keywords
data
dose
administration
subject
model
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004514009A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005534899A5 (cg-RX-API-DMAC7.html
JP2005534899A (ja
Inventor
トマス・アンドルー・クレイトン
ジェレミー・ラムゼー・エヴェレット
ジョン・クリストファー・リンドン
ジェレミー・カーク・ニコルソン
Original Assignee
ファイザー・インク
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0213786A external-priority patent/GB0213786D0/en
Priority claimed from GB0213895A external-priority patent/GB0213895D0/en
Application filed by ファイザー・インク filed Critical ファイザー・インク
Publication of JP2005534899A publication Critical patent/JP2005534899A/ja
Publication of JP2005534899A5 publication Critical patent/JP2005534899A5/ja
Application granted granted Critical
Publication of JP4829496B2 publication Critical patent/JP4829496B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Saccharide Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
JP2004514009A 2002-06-14 2003-06-16 代謝表現型 Expired - Fee Related JP4829496B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0213786A GB0213786D0 (en) 2002-06-14 2002-06-14 Metabolic phenotyping
GB0213786.7 2002-06-14
GB0213895.6 2002-06-17
GB0213895A GB0213895D0 (en) 2002-06-17 2002-06-17 Metabolic phenotyping
PCT/IB2003/002309 WO2003107270A2 (en) 2002-06-14 2003-06-16 Metabolic phenotyping

Publications (3)

Publication Number Publication Date
JP2005534899A JP2005534899A (ja) 2005-11-17
JP2005534899A5 JP2005534899A5 (cg-RX-API-DMAC7.html) 2006-07-27
JP4829496B2 true JP4829496B2 (ja) 2011-12-07

Family

ID=29738094

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004514009A Expired - Fee Related JP4829496B2 (ja) 2002-06-14 2003-06-16 代謝表現型

Country Status (15)

Country Link
US (2) US20050074745A1 (cg-RX-API-DMAC7.html)
EP (1) EP1540560B1 (cg-RX-API-DMAC7.html)
JP (1) JP4829496B2 (cg-RX-API-DMAC7.html)
KR (1) KR20050012281A (cg-RX-API-DMAC7.html)
AT (1) ATE502343T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003232406A1 (cg-RX-API-DMAC7.html)
CA (1) CA2487836C (cg-RX-API-DMAC7.html)
DE (1) DE60336403D1 (cg-RX-API-DMAC7.html)
HK (1) HK1080167A1 (cg-RX-API-DMAC7.html)
HR (1) HRP20041174A2 (cg-RX-API-DMAC7.html)
IL (1) IL165329A0 (cg-RX-API-DMAC7.html)
IN (1) IN2004DN03762A (cg-RX-API-DMAC7.html)
NO (1) NO20045111L (cg-RX-API-DMAC7.html)
RU (1) RU2004136317A (cg-RX-API-DMAC7.html)
WO (1) WO2003107270A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2533846C1 (ru) * 2013-05-13 2014-11-20 Сергей Леонидович Устьянцев Способ определения энтропии в организме человека или животного

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040142496A1 (en) * 2001-04-23 2004-07-22 Nicholson Jeremy Kirk Methods for analysis of spectral data and their applications: atherosclerosis/coronary heart disease
US20050037515A1 (en) * 2001-04-23 2005-02-17 Nicholson Jeremy Kirk Methods for analysis of spectral data and their applications osteoporosis
WO2003017177A2 (en) * 2001-08-13 2003-02-27 Beyong Genomics, Inc. Method and system for profiling biological systems
IN2004DN03762A (cg-RX-API-DMAC7.html) 2002-06-14 2010-01-08 Pfizer
WO2005020125A2 (en) * 2003-08-20 2005-03-03 Bg Medicine, Inc. Methods and systems for profiling biological systems
US7534619B2 (en) * 2005-10-27 2009-05-19 Brandon Horn Method for determining metabolic type
US7899625B2 (en) * 2006-07-27 2011-03-01 International Business Machines Corporation Method and system for robust classification strategy for cancer detection from mass spectrometry data
EP2428587A3 (en) * 2006-10-13 2012-07-18 Metabolon Inc. Biomarkers related to metabolic age and methods using the same
US20080286774A1 (en) * 2007-05-16 2008-11-20 The Regents Of The University Of California Real-time individualized therapy evaluation
US20100273203A1 (en) * 2009-04-23 2010-10-28 Board Of Trustees Of The University Of Arkansas Methods and compositions for detecting metabolites
US8660823B2 (en) * 2009-04-26 2014-02-25 Lester F. Ludwig Nonlinear and lie algebra structural analysis system for enzyme cascades, metabolic signal transduction, signaling pathways, catalytic chemical reaction networks, and immunology
GB0912685D0 (en) 2009-07-22 2009-08-26 Imp Innovations Ltd Methods
GB0912744D0 (en) 2009-07-22 2009-08-26 Imp Innovations Ltd Methods and uses
US8410064B2 (en) * 2009-08-24 2013-04-02 The Board Of Trustees Of The University Of Arkansas Classical cannabinoid metabolites and methods of use thereof
US8883218B2 (en) 2010-03-26 2014-11-11 The Board Of Trustees Of The University Of Arkansas Anti-cancer nanoparticle compositions and methods of use
GB201012297D0 (en) * 2010-07-22 2010-09-08 Ge Healthcare Uk Ltd A system and method for automated biological cell assay data analysis
WO2012018535A2 (en) * 2010-07-26 2012-02-09 Wellness Indicators, Inc. Wellness panel
US9095598B2 (en) 2010-12-28 2015-08-04 The Board Of Trustees Of The University Of Arkansas Stilbenoid derivatives and their uses
US9535144B2 (en) 2012-06-01 2017-01-03 Liposcience, Inc. NMR quantification of TMAO
US9470771B2 (en) 2012-06-08 2016-10-18 Liposcience, Inc. NMR measurements of NMR biomarker GlycA
US9928345B2 (en) 2012-06-08 2018-03-27 Liposciences, Inc. Multiple-marker risk parameters predictive of conversion to diabetes
US9361429B2 (en) 2012-06-08 2016-06-07 Liposcience, Inc. Multi-parameter diabetes risk evaluations
CN104215623B (zh) * 2013-05-31 2018-09-25 欧普图斯(苏州)光学纳米科技有限公司 面向多行业检测的激光拉曼光谱智能化辨识方法及系统
US9953417B2 (en) 2013-10-04 2018-04-24 The University Of Manchester Biomarker method
US9519823B2 (en) * 2013-10-04 2016-12-13 The University Of Manchester Biomarker method
CN107764848A (zh) * 2016-08-18 2018-03-06 中国科学院烟台海岸带研究所 一种基于代谢组学评价石斑鱼饲料利用的方法
CN108766587B (zh) * 2018-05-11 2022-05-03 北京诺道认知医学科技有限公司 一种基于指定药物构建给药数据库的方法及装置
CN108717876B (zh) * 2018-05-11 2022-05-20 大连诺道认知医学技术有限公司 一种基于指定药物构建给药数据库的方法及装置
CN108445112B (zh) * 2018-05-29 2021-03-16 云南中烟工业有限责任公司 一种烟叶烟气中4-(n-甲基-n-亚硝胺)-1-(3-吡啶基)-丁酮的检测方法
WO2020081326A1 (en) * 2018-10-15 2020-04-23 Olaris, Inc. Spectographic metabolite-signature for identifying a subject's susceptibility to drugs
JP2022550916A (ja) 2019-10-10 2022-12-05 ジョージア テック リサーチ コーポレイション 深紫外線顕微鏡を用いた無標識の血液学的および組織病理学的分析
ES2955072T3 (es) * 2019-10-17 2023-11-28 Evonik Operations Gmbh Método de predicción de un valor de propiedad de un material usando análisis de componentes principales
CN120359409A (zh) * 2022-08-31 2025-07-22 美国控股实验室公司 通过nmr波谱法测量柠檬酸根和肌酐水平的方法和系统
WO2025028546A1 (ja) * 2023-08-01 2025-02-06 国立大学法人奈良先端科学技術大学院大学 電磁波散乱スペクトルによる細胞判別方法および装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6658396B1 (en) * 1999-11-29 2003-12-02 Tang Sharon S Neural network drug dosage estimation
WO2002010746A2 (en) * 2000-07-28 2002-02-07 Lion Bioscience Ag Pharmacokinetic tool and method for predicting metabolism of a compound in a mammal
IN2004DN03762A (cg-RX-API-DMAC7.html) 2002-06-14 2010-01-08 Pfizer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2533846C1 (ru) * 2013-05-13 2014-11-20 Сергей Леонидович Устьянцев Способ определения энтропии в организме человека или животного

Also Published As

Publication number Publication date
HRP20041174A2 (en) 2005-06-30
HK1080167A1 (zh) 2006-04-21
DE60336403D1 (de) 2011-04-28
NO20045111L (no) 2005-01-12
US20090192721A1 (en) 2009-07-30
KR20050012281A (ko) 2005-01-31
CA2487836A1 (en) 2003-12-24
CA2487836C (en) 2014-12-02
WO2003107270A3 (en) 2005-04-21
WO2003107270A2 (en) 2003-12-24
EP1540560A2 (en) 2005-06-15
US8577617B2 (en) 2013-11-05
US20050074745A1 (en) 2005-04-07
ATE502343T1 (de) 2011-04-15
RU2004136317A (ru) 2006-01-27
AU2003232406A1 (en) 2003-12-31
IL165329A0 (en) 2006-01-15
IN2004DN03762A (cg-RX-API-DMAC7.html) 2010-01-08
JP2005534899A (ja) 2005-11-17
EP1540560B1 (en) 2011-03-16

Similar Documents

Publication Publication Date Title
JP4829496B2 (ja) 代謝表現型
Robertson et al. Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants
Connor et al. Effects of feeding and body weight loss on the 1H-NMR-based urine metabolic profiles of male Wistar Han rats: implications for biomarker discovery
Shearer et al. Metabolomic profiling of dietary‐induced insulin resistance in the high fat–fed C57BL/6J mouse
Winnike et al. Use of pharmaco‐metabonomics for early prediction of acetaminophen‐induced hepatotoxicity in humans
Lindon et al. Peer reviewed: so what’s the deal with metabonomics?
Griffin et al. Metabonomics: its potential as a tool in toxicology for safety assessment and data integration
Gavaghan et al. Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS-DA
Gavaghan et al. An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk: ApfCD mouse
Wang et al. Global metabolic responses of mice to Trypanosoma brucei brucei infection
Beckonert et al. NMR-based metabonomic toxicity classification: hierarchical cluster analysis and k-nearest-neighbour approaches
Weljie et al. Targeted profiling: quantitative analysis of 1H NMR metabolomics data
Gu et al. 1H NMR metabolomics study of age profiling in children
Wang et al. System level metabolic effects of a Schistosoma japonicum infection in the Syrian hamster
Gu et al. Enantioselective effects of metalaxyl enantiomers in adolescent rat metabolic profiles using NMR-based metabolomics
JP2004526130A (ja) スペクトル解析法及びその応用：スペクトル交換
Cunningham et al. Pharmacometabonomic characterization of xenobiotic and endogenous metabolic phenotypes that account for inter-individual variation in isoniazid-induced toxicological response
Baraldi et al. Metabolomics: moving towards personalized medicine
Fanos et al. Pharma-metabolomics in neonatology: is it a dream or a fact?
Griffith et al. Metabolic profiling of chloroacetanilide herbicides in earthworm coelomic fluid using 1H NMR and GC–MS
Vendramini et al. Serum metabolomics analysis reveals that weight loss in obese dogs results in a similar metabolic profile to dogs in ideal body condition
Finch et al. Preliminary demonstration of benchtop NMR metabolic profiling of feline urine: chronic kidney disease as a case study
Um et al. Nuclear magnetic resonance-based metabolomics for prediction of gastric damage induced by indomethacin in rats
Grootveld et al. Updates and original case studies focused on the NMR-linked metabolomics analysis of human oral fluids Part I: Emerging platforms and perspectives
Correia et al. 1H NMR signals from urine excreted protein are a source of bias in probabilistic quotient normalization

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060609

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060609

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090616

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090907

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090917

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091215

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100622

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100921

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101004

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101207

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110823

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110916

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140922

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees